/Labcorp%20Holdings%20Inc_%20location-by%20Sundry%20Photography%20via%20iStock.jpg)
Valued at a market cap of $20 billion, Labcorp Holdings Inc. (LH) is a leading healthcare diagnostics company that provides comprehensive clinical laboratory services and end-to-end drug development support. The Burlington, North Carolina-based company serves doctors, hospitals, pharmaceutical companies, biotechnology companies, medical devices, diagnostics and crop protection companies, and chemical companies.
Shares of this healthcare company have underperformed the broader market over the past 52 weeks. LH has gained 13.4% over this time frame, while the broader S&P 500 Index ($SPX) has soared 31.3%. Moreover, on a YTD basis, the stock is up 6.2%, compared to SPX’s 25.5% gain.